Patrick Schrauwen is an expert in Endocrinology at German Diabetes Center (Germany). As of October 2026, ScienceLeadR ranks Patrick Schrauwen in the top 1% of experts worldwide for Insulin Resistance, Hyperinsulinism and Glucose Metabolism Disorders. Patrick Schrauwen has authored 383 publications, the most recent in 2026, and is an investigator in 40 clinical trials, 1 of them ongoing. SLR score: 2,297 (community average: 125). How the SLR is computed.

LeadR Profile

Patrick Schrauwen German Diabetes Center Germany
2 297 ScienceLeadR Reputation 2297
Network Map

Endocrinology

Subspecialties: Public Health - Gastroenterology - Rheumatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026

Source: PubMed

Maastricht University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 383

Citations

Citations: 33 136 1st author: 41 Last author: 116 Unique author: 8


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Changing gears: a journey from sport to science to Editor-in-Chief.
PMID 42944903 — diabetes mellitus, sports
Diabetologia20260
Metabolic benefits of ketohexokinase inhibition in individuals with MASLD: a randomized placebo-controlled crossover trial.
PMID 42844400 — insulin, tissues, adipose tissue, fructose
Nat Metab20262
Longer lipids mark aging and constrain lifespan.
PMID 42839094 — aging, tissues
Nat Aging20261
Insulin resistance in the 21st century: new takes on an old problem-2025 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
PMID 42803809 — diabetes mellitus, insulin resistance, insulin, research, therapeutics, diabetes mellitus, type 2
Diabetologia20261
Insulin Resistance in the 21st Century: New Takes on an Old Problem-2025 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
PMID 42803375 — diabetes mellitus, insulin resistance, insulin, research, therapeutics, diabetes mellitus, type 2
Diabetes Care20260

Clinical Studies 40

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 14 Study Director: 3

By phase:

N/A 31
Phase 2 5
Phase 4 3
Phase 3 1

By status:

Completed 33
Recruiting 3
Terminated 2
Unknown 2

By type:

Interventional 33
Observational 7

By Monocentric/Multicentric:

monocentric 37
multicentric2to4 3
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Exercise Chronotype and Prediabetes
NCT07389005 — exercise, exercise test, motor activity, prediabetic state, obesity, overweight
N/ARecruiting2026

LeadR Networks

Main global connection map